Praxis Packaging Solutions Turns to TraceLink for DSCSA Compliance
— Chooses TraceLink for Serialization After Ending DSCSA Project with Another Vendor
North Reading, MA (October 10, 2017)—TraceLink Inc., the World’s Largest Track and Trace Network for connecting the life sciences supply chain and providing real-time information sharing for better patient outcomes, today announced that Praxis Packaging Solutions has selected TraceLink to help its pharmaceutical manufacturing customers comply with the serialization deadline for the U.S. Drug Supply Chain Security Act (DSCSA). After experiencing connectivity challenges with another vendor’s serialization solution, Praxis turned to TraceLink to eliminate point-to-point integration complexities, meet the DSCSA serialization deadline and reduce business risk for its pharmaceutical customers.
Established in 1989 and headquartered in Michigan, Praxis Packaging Solutions is a full service contract packaging organization (CPO) specializing in secondary packaging operations for the pharmaceutical industry. To prepare for DSCSA, Praxis originally selected another serialization vendor that was providing both hardware and software solutions, but quickly experienced challenges when the vendor’s software solution was unable to connect with their customers. As a result, the contract packaging company turned to TraceLink for its market-leading integration expertise and proven abilities in data exchange and partner connections.
“Praxis ensures that product quality and consumer safety are at the forefront of everything we do. We needed a cost-effective serialization solution provider that was proven in providing an end to end digital supply chain network, with the agility to quickly connect and validate the brands within our infrastructure,” said Scott Hanmer of Praxis Packaging. “Now that TraceLink is integrated into our overall serialization program, we can provide our customers with the highest levels of product control and tracking throughout our part of the supply chain, from our receipt of incoming product until the time we ship the finished goods.”
“We are pleased that Praxis chose TraceLink as its long-term serialization partner for DSCSA compliance. By quickly recognizing the critical need to migrate from its former point-to-point serialization system to TraceLink’s interoperable, integrate-once network platform, Praxis is raising the bar with their serialization strategy,” said Shabbir Dahod, president and CEO of TraceLink. “As pharmaceutical companies realize the complexities of serialization and the need for unprecedented scalability and seamless data exchange, they continue to turn to TraceLink to leverage our network expertise and rapid implementation at the lowest possible cost.”
With the DSCSA enforcement delay for manufacturers, pharmaceutical companies are taking the opportunity to refine their serialization programs. Currently, TraceLink is the only solution provider with over 120 companies serialization-ready, enabling companies like Praxis Packaging to leverage a networkcentric serialization infrastructure that minimizes connections and maximizes reuse of resources across a diverse customer base, in order to meet the DSCSA serialization deadline.
To learn more about meeting global pharmaceutical compliance deadlines and how to build a flexible serialization, track and trace, and reporting platform for the U.S., the EU, and other global regulations, please visit: www.tracelink.com.
TraceLink is the World’s Largest Track and Trace Network for connecting the Life Sciences supply chain and eliminating counterfeit prescription drugs from the global marketplace. Leading businesses trust the TraceLink Life Sciences Cloud to deliver complete global connectivity, visibility and traceability of pharmaceuticals from ingredient to patient. A single point and click connection to the Life Sciences Cloud creates a supply chain control tower that delivers the information, insight and collaboration needed to improve performance and reduce risk across global supply, manufacturing and distribution operations. A winner of numerous industry awards including Deloitte’s Technology Fast 500 (ranked number 149 in 2016), the Amazon AWS Global Start-Up Challenge Grand Prize, and the Edison Award for Innovation in Health Management, the Life Sciences Cloud is used by businesses across the globe to meet strategic goals in ensuring global compliance, fighting drug counterfeiting, improving ontime and in-full delivery, protecting product quality and reducing operational cost. For more information on TraceLink and our solutions, visit www.tracelink.com or follow us on LinkedIn, Twitter and Facebook.
TraceLink is funded by Goldman Sachs, FirstMark Capital, Volition Capital and F-Prime Capital.
Director, Corporate Communications